Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

. 2019 Mar 30 ; 24 (7) : . [epub] 20190330

Jazyk angličtina Země Švýcarsko Médium electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid30935016

Grantová podpora
RVO 61388971 RVO - International CEP - Centrální evidence projektů

Glucans are part of a group of biologically active natural molecules and are steadily gaining strong attention not only as an important food supplement, but also as an immunostimulant and potential drug. This paper represents an up-to-date review of glucans (β-1,3-glucans) and their role in various immune reactions and the treatment of cancer. With more than 80 clinical trials evaluating their biological effects, the question is not if glucans will move from food supplement to widely accepted drug, but how soon.

Zobrazit více v PubMed

Scrimshaw N.S. Historical concepts of interactions, synergism and antagonism between nutrition and infection. J. Nutr. 2003;133:316S–321S. doi: 10.1093/jn/133.1.316S. PubMed DOI

Chandra R.K. Nutrition and immunology: From the clinic to cellular biology and back again. Proc. Nutr. Soc. 1999;58:681–683. doi: 10.1017/S0029665199000890. PubMed DOI

Mainous M.R., Deitch E.A. Nutrition and infection. Surg. Clin. N. Am. 1994;74:659–676. doi: 10.1016/S0039-6109(16)46335-8. PubMed DOI

Chandra R.K. Nutrition and Immunology. ARTS Biomedical; St John’s, NL, Canada: 1992.

Plata-Salaman C.R. Cytokines and feeding. Int. J. Obes. Relat. Metab. Disord. 2001;25(Suppl. 5):S48–S52. doi: 10.1038/sj.ijo.0801911. PubMed DOI

Donabedian H. Nutritional therapy and infectious diseases: A two-edged sword. Nutr. J. 2006;5:21. doi: 10.1186/1475-2891-5-21. PubMed DOI PMC

Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biotechnol. 2002;60:258–274. doi: 10.1007/s00253-002-1076-7. PubMed DOI

Vetvicka V., Vetvickova J. Natural immunomodulators and their stimulation of immune reaction: True or false? Anticancer Res. 2014;34:2275–2282. PubMed

Zipfel C., Robatzek S. Pathogen-associated molecular pattern-triggered immunity: Veni, vidi...? Plant Physiol. 2010;154:551–554. doi: 10.1104/pp.110.161547. PubMed DOI PMC

Shear M.J., Turner F.C., Perrault A., Shovelton T. Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate. J. Natl. Cancer Inst. 1943;4:81–97. doi: 10.1093/jnci/4.1.81. DOI

Rathgeb P., Sylven B. Fractionation studies on the tumor-necrotizing agent from Serratia marcescens (Shear’s polysaccharide) J. Natl. Cancer Inst. 1954;14:1099–1108. PubMed

Yang J., Tu J., Liu H., Wen L., Jiang Y., Yang B. Identification of an immunostimulatory polysaccharide in banana. Food Chem. 2019;277:46–53. doi: 10.1016/j.foodchem.2018.10.043. PubMed DOI

Iwanaga S., Lee B.L. Recent advances in the innate immunity of invertebrate animals. J. Biochem. Mol. Biol. 2005;38:128–150. doi: 10.5483/BMBRep.2005.38.2.128. PubMed DOI

Soltanian S., Stuyven E., Cox E., Sorgeloos P., Bossier P. Beta-glucans as immunostimulant in vertebrates and invertebrates. Crit. Rev. Microbiol. 2009;35:109–138. doi: 10.1080/10408410902753746. PubMed DOI

Riggi S.J., Di Luzio N.R. Identification of a reticuloendothelial stimulating agent in zymosan. Am. J. Physiol. 1961;200:297–300. doi: 10.1152/ajplegacy.1961.200.2.297. PubMed DOI

Bohn J.A., BeMiller J.N. (1→3)-β-d-Glucans as biological response modifiers: A review of structure-functional activity relationships. Carbohydr. Polym. 1995;28:3–14. doi: 10.1016/0144-8617(95)00076-3. DOI

Novak M., Vetvicka V. Development of views on β-glucan composition and structure. In: Vetvicka V., Novak M., editors. Biology and Chemistry of Beta Glucan. Volume 1. Bentham Science; Sharjah, UAE: 2011. pp. 1–9.

Vetvicka V., Dvorak B., Vetvickova J., Richter J., Krizan J., Sima P., Yvin J.C. Orally administered marine (1-->3)-beta-d-glucan Phycarine stimulates both humoral and cellular immunity. Int. J. Biol. Macromol. 2007;40:291–298. doi: 10.1016/j.ijbiomac.2006.08.009. PubMed DOI

Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., Xing P.X., Cheung N.K., Ross G.D. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 2004;173:797–806. doi: 10.4049/jimmunol.173.2.797. PubMed DOI

Chan G.C., Chan W.K., Sze D.M. The effects of beta-glucan on human immune and cancer cells. J. Hematol. Oncol. 2009;2:25–35. doi: 10.1186/1756-8722-2-25. PubMed DOI PMC

Moriyuki H., Ichimura M. Acute toxicity of lentinan in mice and rats (author’s transl) J. Toxicol. Sci. 1980;5:1–9. doi: 10.2131/jts.5.Supplement_1. PubMed DOI

Vetvicka V., Richter J., Svozil V., Rajnohova Dobiasova L., Kral V. Placebo-driven clinical trials of Transfer Point Glucan #300 in children with chronic respiratory problems: Antibody production. Am. J. Immunol. 2013;9:43–47. doi: 10.3844/ajisp.2013.43.47. DOI

Dawood M.A.O., Eweedah N.M., Moustafa E.M., Shahin M.G. Synbiotic effects of Aspergillus oryzae and beta-glucan on growth and oxidative and immune responses of Nile tilapia, Oreochromis niloticus. Probiot. Antimicrob. Proteins. 2019 doi: 10.1007/s12602-018-9513-9. PubMed DOI

Mukhopadhya A., O’Doherty J.V., Sweeney T. A combination of yeast beta-glucan and milk hydrolysate is a suitable alternative to zinc oxide in the race to alleviate post-weaning diarrhoea in piglets. Sci. Rep. 2019;9:616. doi: 10.1038/s41598-018-37004-9. PubMed DOI PMC

Anusuya S., Sathiyabama M. Foliar application of beta-D-glucan nanoparticles to control rhizome rot disease of turmeric. Int. J. Biol. Macromol. 2015;72:1205–1212. doi: 10.1016/j.ijbiomac.2014.10.043. PubMed DOI

Menard R., de Ruffray P., Fritig B., Yvin J.C., Kauffmann S. Defense and resistance-inducing activities in tobacco of the sulfated beta-1,3 glucan PS3 and its synergistic activities with the unsulfated molecule. Plant Cell Physiol. 2005;46:1964–1972. doi: 10.1093/pcp/pci212. PubMed DOI

Al Tuwaijri A.S., Mahmoud A.A., Al Mofleh I.A., Al Khuwaitir S.A. Effect of glucan on Leishmania major infection in BALB/c mice. J. Med. Microbiol. 1987;23:363–365. doi: 10.1099/00222615-23-4-363. PubMed DOI

Cook J.A., Holbrook T.W. Immunogenicity of soluble and particulate antigens from Leishmania donovani: Effect of glucan as an adjuvant. Infect. Immun. 1983;40:1038–1043. PubMed PMC

Bacon J.S., Farmer V.C. The presence of a predominantly beta(1-6)component in preparations of yeast glucan. Biochem. J. 1968;110:34P–35P. doi: 10.1042/bj1100034Pb. PubMed DOI PMC

Bousquet M., Escoula L., Pipy B., Bessieres M.H., Chavant L., Seguela J.P. Enhancement of resistance of mice Toxoplasma gondii by 2 polysaccharides beta 1-3, beta 1-6 (PSAT and Scleroglucan) Ann. Parasitol. Hum. Comp. 1988;63:398–409. doi: 10.1051/parasite/1988636398. PubMed DOI

Dritz S.S., Shi J., Kielian T.L., Goodband R.D., Nelssen J.L., Tokach M.D., Chengappa M.M., Smith J.E., Blecha F. Influence of dietary beta-glucan on growth performance, nonspecific immunity, and resistance to Streptococcus suis infection in weanling pigs. J. Anim. Sci. 1995;73:3341–3350. doi: 10.2527/1995.73113341x. PubMed DOI

Kumar P., Ahmad S. Glucan-induced immunity in mice against Plasmodium berghei. Ann. Trop. Med. Parasitol. 1985;79:211–213. doi: 10.1080/00034983.1985.11811908. PubMed DOI

Liang J., Melican D., Cafro L., Palace G., Fisette L., Armstrong R., Patchen M.L. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int. J. Immunopharmacol. 1998;20:595–614. doi: 10.1016/S0192-0561(98)00007-1. PubMed DOI

Rasmussen L.T., Seljelid R. Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose derivatives. I. Cells. Scand. J. Immunol. 1990;32:321–331. doi: 10.1111/j.1365-3083.1990.tb02926.x. PubMed DOI

White T.R., Thompson R.C., Penhale W.J., Chihara G. The effect of lentinan on the resistance of mice to Mesocestoides corti. Parasitol. Res. 1988;74:563–568. doi: 10.1007/BF00531635. PubMed DOI

Williams D.L., Yaeger R.G., Pretus H.A., Browder I.W., McNamee R.B., Jones E.L. Immunization against Trypanosoma cruzi: Adjuvant effect of glucan. Int. J. Immunopharmacol. 1989;11:403–410. doi: 10.1016/0192-0561(89)90087-8. PubMed DOI

Yun C.H., Estrada A., Van Kessel A., Gajadhar A., Redmond M., Laarveld B. Immunomodulatory effects of oat beta-glucan administered intragastrically or parenterally on mice infected with Eimeria vermiformis. Microbiol. Immunol. 1998;42:457–465. PubMed

Vetvicka V., Terayam K., Mandeville R., Brousseau P., Kournikakis B., Ostroff G. Pilot study: Orally-administered yeast β1,3-glucan prophylactically protects against anthrax infectin and cancer in mice. JANA. 2002;5:1–5.

Nakao I., Uchino H., Orita K., Kaido I., Kimura T., Goto Y., Kondo T., Takino T., Taguchi T., Nakajima T., et al. Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer—A randomized comparative study by an envelope method. Gan To Kagaku Ryoho. 1983;10:1146–1159. PubMed

Malyarenko O.S., Usoltseva R.V., Zvyagintseva T.N., Ermakova S.P. Laminaran from brown alga Dictyota dichotoma and its sulfated derivative as radioprotectors and radiosensitizers in melanoma therapy. Carbohydr. Polym. 2019;206:539–547. doi: 10.1016/j.carbpol.2018.11.008. PubMed DOI

Bouike G., Nishitani Y., Shiomi H., Yoshida M., Azuma T., Hashimoto T., Kanazawa K., Mizuno M. Oral treatment with extract of Agaricus blazei murill enhanced Th1 Response through intestinal epithelial cells and suppressed OVA-sensitized allergy in mice. Evid. Based Complement. Altern. Med. 2011;2011:532180. doi: 10.1155/2011/532180. PubMed DOI PMC

Hong F., Hansen R.D., Yan J., Allendorf D.J., Baran J.T., Ostroff G.R., Ross G.D. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 2003;63:9023–9031. PubMed

Ross G.D., Vetvicka V., Yan J., Xia Y., Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 1999;42:61–74. doi: 10.1016/S0162-3109(99)00013-2. PubMed DOI

Xu H., Zou S., Xu X. The beta-glucan from Lentinus edodes suppresses cell proliferation and promotes apoptosis in estrogen receptor positive breast cancers. Oncotarget. 2017;8:86693–86709. doi: 10.18632/oncotarget.21411. PubMed DOI PMC

Fortin O., Aguilar-Uscanga B.R., Vu K.D., Salmieri S., Lacroix M. Effect of Saccharomyces boulardii cell wall extracts on colon cancer prevention in male F344 rats treated with 1,2-dimethylhydrazine. Nutr. Cancer. 2018;70:632–642. doi: 10.1080/01635581.2018.1460672. PubMed DOI

Větvička V.C. [Beta]-Glucans as Natural Biological Response Modifiers. Nova Science Publishers, Inc.; New York, NY, USA: 2013.

Schepetkin I.A., Quinn M.T. Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 2006;6:317–333. doi: 10.1016/j.intimp.2005.10.005. PubMed DOI

Vetvicka V., Vetvickova J. Physiological effects of different types of beta-glucan. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2007;151:225–231. doi: 10.5507/bp.2007.038. PubMed DOI

Ali M.F., Driscoll C.B., Walters P.R., Limper A.H., Carmona E.M. Beta-glucan-activated human B lymphocytes participate in innate immune responses by releasing proinflammatory cytokines and stimulating neutrophil chemotaxis. J. Immunol. 2015;195:5318–5326. doi: 10.4049/jimmunol.1500559. PubMed DOI PMC

Elcombe S.E., Naqvi S., Van Den Bosch M.W., MacKenzie K.F., Cianfanelli F., Brown G.D., Arthur J.S. Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markers. PLoS ONE. 2013;8:e60086. doi: 10.1371/journal.pone.0060086. PubMed DOI PMC

Municio C., Alvarez Y., Montero O., Hugo E., Rodriguez M., Domingo E., Alonso S., Fernandez N., Crespo M.S. The response of human macrophages to beta-glucans depends on the inflammatory milieu. PLoS ONE. 2013;8:e62016. doi: 10.1371/journal.pone.0062016. PubMed DOI PMC

Bashir K.M.I., Choi J.S. Clinical and physiological perspectives of beta-glucans: The past, present, and future. Int. J. Mol. Sci. 2017;18:1906. doi: 10.3390/ijms18091906. PubMed DOI PMC

Chan A.S., Jonas A.B., Qiu X., Ottoson N.R., Walsh R.M., Gorden K.B., Harrison B., Maimonis P.J., Leonardo S.M., Ertelt K.E., et al. Imprime PGG-mediated anti-cancer immune activation requires immune complex formation. PLoS ONE. 2016;11:e0165909. doi: 10.1371/journal.pone.0165909. PubMed DOI PMC

Vetvicka V., Novak M. Biology and Chemistry of Beta Glucan. Volume 1 Bentham Science; Sharjah, UAE: 2011.

Li X., Chen P., Zhang P., Chang Y., Cui M., Duan J. Protein-bound beta-glucan from Coriolus versicolor has potential for use against obesity. Mol. Nutr. Food Res. 2019:e1801231. doi: 10.1002/mnfr.201801231. PubMed DOI

Vetvicka V., Gover O., Karpovsky M., Hayby H., Danay O., Ezov N., Hadar Y., Schwartz B. Immune-modulating activities of glucans extracted from Pleurotus ostreatus and Pleurotus eryngii. J. Funct. Foods. 2019;54:81–91. doi: 10.1016/j.jff.2018.12.034. DOI

Vetvicka V., Vetvickova J. Glucan supplementation ameliorates some health problems related to the development of Lyme disease. World J. Pathol. 2019;8:7–13.

Berdal M., Appelbom H.I., Eikrem J.H., Lund A., Zykova S., Busund L.T., Seljelid R., Jenssen T. Aminated beta-1,3-D-glucan improves wound healing in diabetic db/db mice. Wound Repair Regen. 2007;15:825–832. doi: 10.1111/j.1524-475X.2007.00286.x. PubMed DOI

Gulcelik M.A., Dincer H., Sahin D., Faruk Demir O., Yenidogan E., Alagol H. Glucan improves impaired wound healing in diabetic rats. Wounds. 2010;22:12–16. PubMed

Takatsuki F., Namiki R., Kikuchi T., Suzuki M., Hamuro J. Lentinan augments skin reaction induced by bradykinin: Its correlation with vascular dilatation and hemorrhage responses and antitumor activities. Int. J. Immunopharmacol. 1995;17:465–474. doi: 10.1016/0192-0561(95)00037-3. PubMed DOI

Gaspar L.R., Camargo F.B., Jr., Gianeti M.D., Maia Campos P.M. Evaluation of dermatological effects of cosmetic formulations containing Saccharomyces cerevisiae extract and vitamins. Food Chem. Toxicol. 2008;46:3493–3500. doi: 10.1016/j.fct.2008.08.028. PubMed DOI

Pillai R., Redmond M., Röding J. Anti-wrinkle therapy: Significant new findings in the non-invasive cosmetic treatment of skin wrinkles with beta-glucan. Int. J. Cosmet. Sci. 2005;27:292. doi: 10.1111/j.1463-1318.2005.00268_3.x. DOI

O’Day S., Stopeck A., Huhn R., Gargano M., Prathikanti R., Ma B., Mattson P., Lowe J., Bose N., Ertelt K., et al. Abstract OT1-01-04: A phase 2, open-label study of imprime PGG (Imprime), a novel beta glucan, with pembrolizumab (Pembro) in chemotherapy-resistant metastatic triple negative breast cancer (TNBC) Cancer Res. 2018;78 doi: 10.1158/1538-7445.SABCS17-OT1-01-04. DOI

Tamayo M.E., Cornelio G.H., Bautista J.B., Flores M.L., Kurman M.R., Paul M.M., Gargano M.A., Patchen M.L. A phase Ib/2, dose-escalating, safety, and efficacy study of imprime PGG, cetuximab and irinotecan in patients with advanced colorectal cancer (CRC) J. Clin. Oncol. 2009;27:e15062. doi: 10.1200/jco.2009.27.15s.e15062. DOI

Wesa K.M., Cunningham-Rundles S., Klimek V.M., Vertosick E., Coleton M.I., Yeung K.S., Lin H., Nimer S., Cassileth B.R. Maitake mushroom extract in myelodysplastic syndromes (MDS): A phase II study. Cancer Immunol. Immunother. 2015;64:237–247. doi: 10.1007/s00262-014-1628-6. PubMed DOI PMC

Aleem E. β-Glucans and their applications in cancer therapy: Focus on human studies. Anticancer Agents Med. Chem. 2013;13:709–719. doi: 10.2174/1871520611313050005. PubMed DOI

Vetvicka V., Vetvickova J. Glucans and cancer: Comparison of commercially available β-glucans—Part IV. Anticancer Res. 2018;38:1327–1333. doi: 10.21873/anticanres.12355. PubMed DOI

Richter J., Kral V., Stiborova I., Rajnohova D., Vetvicka V. Anti-inflammatory effects of β-glucan in cancer related fatigue. J. Nutr. Health Sci. 2015;2:304–310. doi: 10.15744/2393-9060.2.304. DOI

Richter J., Kral V., Svozil V., Rajnohova Dobiasova L., Pohorska J., Stiborova I., Vetvicka V. Effect of Transfer Point Glucan #300 supplementation on children exposed to passive smoking: Placebo-driven double-blind trials. J. Nutr. Health. 2014;1:105–111.

Richter J., Svozil V., Kral V., Rajnohova Dobiasova L., Stiborova I., Vetvicka V. Clinical trials of yeast-derived beta-(1,3) glucan in children: Effects on innate immunity. Ann. Transl. Med. 2014;2:15. doi: 10.3978/j.issn.2305-5839.2014.02.01. PubMed DOI PMC

Fuller R., Moore M.V., Lewith G., Stuart B.L., Ormiston R.V., Fisk H.L., Noakes P.S., Calder P.C. Yeast-derived beta-1,3/1,6 glucan, upper respiratory tract infection and innate immunity in older adults. Nutrition. 2017;39–40:30–35. doi: 10.1016/j.nut.2017.03.003. PubMed DOI

Richter J., Kral V., Vetvicka V., Lucie R.D., Fernandez-Botran R. Effect of beta-glucan supplementation on levels of IgM, IgA, IgG and its subclasses IgG1, IgG2, IgG3, and IgG4 in cancer patients. J. Tumor. 2016;4:469–473.

Vetvicka V., Richter J., Kral V., Rajnohova Dobiasova L., Stiborova I., Pohorska J. Regulation of hematopoiesis in cancer patients: Placebor driven, double-blind clinical trials of β-glucan. J. Tumor. 2015;3:305–308.

Pohorska J., Richter J., Kral V., Rajonohova Dobiasova L., Stiborova I., Vetvicka V. Reconstruction of NK cells during complex cancer treatment. J. Tumor. 2016;4:398–402. doi: 10.17554/j.issn.1819-6187.2016.04.86. DOI

Stier H., Ebbeskotte V., Gruenwald J. Immune-modulatory effects of dietary yeast beta-1,3/1,6-D-glucan. Nutr. J. 2014;13:38. doi: 10.1186/1475-2891-13-38. PubMed DOI PMC

Wang Y., Ames N.P., Tun H.M., Tosh S.M., Jones P.J., Khafipour E. High molecular weight barley beta-glucan alters gut microbiota toward reduced cardiovascular disease risk. Front. Microbiol. 2016;7:129. doi: 10.3389/fmicb.2016.00129. PubMed DOI PMC

Richter J., Zavorkova M., Vetvicka V., Liehneova I., Kral V., Dobiasova L.R. Effects of B-glucan and vitamin D supplementation on inflammatory parameters in patients with diabetic retinopathy. J. Diet. Suppl. 2018;19:1–10. doi: 10.1080/19390211.2018.1458769. PubMed DOI

Richter J., Zavorkova M., Vetvicka V., Vlastimil K., Stiborova I., Liehneova I., Pohorska J., Rajnohova D.L. IgG4-related orbital disease in patients with diabetic retinopathy: Effects of glucan and vitamin D supplementation. Pathol. Discov. 2018;6:1–7.

Markovina N., Banjari I., Bucevic Popovic V., Jelicic Kadic A., Puljak L. Efficacy and safety of oral and inhalation commercial beta-glucan products: Systematic review of randomized controlled trials. Clin. Nutr. 2019 doi: 10.1016/j.clnu.2019.01.003. PubMed DOI

Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995;125:1401–1412. doi: 10.1093/jn/125.6.1401. PubMed DOI

de Jesus Raposo M.F., de Morais A.M., de Morais R.M. Emergent sources of prebiotics: Seaweeds and microalgae. Mar. Drugs. 2016;14:27. doi: 10.3390/md14020027. PubMed DOI PMC

Malkki Y., Virtanen E. Gastrointestinal effects of oat bran and oat gum—A review. Lebensm.-Wiss. Technol. 2001;34:337–347. doi: 10.1006/fstl.2001.0795. DOI

Ngamkala S., Futami K., Endo M., Maita M., Katagiri T. Immunological effects of glucan and Lactobacillus rhamnosus GG, a probiotic bacterium, on Nile tilapia Oreochromis niloticus intestine with oral Aeromonas challenges. Fish. Sci. 2010;76:833–840. doi: 10.1007/s12562-010-0280-0. DOI

Rosburg V., Boylston T., White P. Viability of bifidobacteria strains in yogurt with added oat beta-glucan and corn starch during cold storage. J. Food Sci. 2010;75:C439–C444. doi: 10.1111/j.1750-3841.2010.01620.x. PubMed DOI

Szymańska-Czerwińska M., Bednarek D. Effect of tylosin and prebiotics on the selected humoral immunological parameters in calves. Medycyna Wet. 2011;67:275–278.

Nakashima A., Yamada K., Iwata O., Sugimoto R., Atsuji K., Ogawa T., Ishibashi-Ohgo N., Suzuki K. β-Glucan in foods and its physiological functions. J. Nutr. Sci. Vitaminol. (Tokyo) 2018;64:8–17. doi: 10.3177/jnsv.64.8. PubMed DOI

Jenkins D.J., Kendall C.W., Axelsen M., Augustin L.S., Vuksan V. Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr. Opin. Lipidol. 2000;11:49–56. doi: 10.1097/00041433-200002000-00008. PubMed DOI

Fadel J.G., Newman R.K., Newman C.W., Barnes A.E. Hypocholesterolemic effects of beta-glucans in different barley diets fed to broiler chicks. Nutr. Rep. Int. 1987;35:1049–1058.

Lim M.K., Ku S.K., Choi J.S., Kim J.W. Effect of polycan, a beta-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model. Exp. Ther. Med. 2015;9:1369–1378. doi: 10.3892/etm.2015.2238. PubMed DOI PMC

Kusmiati, Dhewantara F.X. Cholesterol-lowering effect of beta glucan extracted from Saccharomyces cerevisiae in rats. Sci. Pharm. 2016;84:153–165. doi: 10.3797/scipharm.ISP.2015.07. PubMed DOI PMC

Anderson J.W., Gustafson N.J. Hypocholesterolemic effects of oat and bean products. Am. J. Clin. Nutr. 1988;48:749–753. doi: 10.1093/ajcn/48.3.749. PubMed DOI

Anderson J.W., Story L., Sieling B., Chen W.J., Petro M.S., Story J. Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am. J. Clin. Nutr. 1984;40:1146–1155. doi: 10.1093/ajcn/40.6.1146. PubMed DOI

Chen J., Huang X.F. The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. J. Clin. Lipidol. 2009;3:154–158. doi: 10.1016/j.jacl.2009.04.054. PubMed DOI

Rondanelli M., Opizzi A., Monteferrario F., Klersy C., Cazzola R., Cestaro B. Beta-glucan- or rice bran-enriched foods: A comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men. Eur. J. Clin. Nutr. 2011;65:864–871. doi: 10.1038/ejcn.2011.48. PubMed DOI

Sima P., Vannucci L., Vetvicka V. β-glucans and cholesterol (Review) Int. J. Mol. Med. 2018;41:1799–1808. doi: 10.3892/ijmm.2018.3411. PubMed DOI PMC

Vetvicka V., Vetvickova J. A comparison of injected and orally administered beta glucans. JANA. 2008;11:42–49.

Hashimoto K., Suzuki I., Yadomae T. Oral administration of SSG, a beta-glucan obtained from Sclerotinia sclerotiorum, affects the function of Peyer’s patch cells. Int. J. Immunopharmacol. 1991;13:437–442. doi: 10.1016/0192-0561(91)90014-X. PubMed DOI

Rice P.J., Adams E.L., Ozment-Skelton T., Gonzalez A.J., Goldman M.P., Lockhart B.E., Barker L.A., Breuel K.F., Deponti W.K., Kalbfleisch J.H., et al. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J. Pharmacol. Exp. Ther. 2005;314:1079–1086. doi: 10.1124/jpet.105.085415. PubMed DOI

Zhang M., Kim J.A., Huang A.Y. Optimizing Tumor microenvironment for cancer immunotherapy: Beta-glucan-based nanoparticles. Front. Immunol. 2018;9:341. doi: 10.3389/fimmu.2018.00341. PubMed DOI PMC

Ostroff G.R., Easson D.D., Jamas S. Polymeric Drugs and Drug Delivery Systems. Volume 469. American Chemical Society; Washington, DC, USA: 1991. A new β-glucan-based macrophage-targeted adjuvant; pp. 52–59.

Fujiwara N., Izumi H., Morimoto Y., Sakurai K., Mochizuki S. Complex consisting of antisense DNA and beta-glucan promotes internalization into cell through Dectin-1 and hybridizes with target mRNA in cytosol. Cancer Gene Ther. 2019;26:32–40. doi: 10.1038/s41417-018-0033-2. PubMed DOI

Jones D.H., Corris S., McDonald S., Clegg J.C., Farrar G.H. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 1997;15:814–817. doi: 10.1016/S0264-410X(96)00266-6. PubMed DOI

Aouadi M., Tesz G.J., Nicoloro S.M., Wang M., Chouinard M., Soto E., Ostroff G.R., Czech M.P. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature. 2009;458:1180–1184. doi: 10.1038/nature07774. PubMed DOI PMC

De Smet R., Demoor T., Verschuere S., Dullaers M., Ostroff G.R., Leclercq G., Allais L., Pilette C., Dierendonck M., De Geest B.G., et al. β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination. J. Control. Release. 2013;172:671–678. doi: 10.1016/j.jconrel.2013.09.007. PubMed DOI

Specht C.A., Lee C.K., Huang H., Tipper D.J., Shen Z.T., Lodge J.K., Leszyk J., Ostroff G.R., Levitz S.M. Protection against experimental cryptococcosis following vaccination with glucan particles containing cryptococcus alkaline extracts. MBio. 2015;6:e01905. doi: 10.1128/mBio.01905-15. PubMed DOI PMC

Soares E., Jesus S., Borges O. Oral hepatitis B vaccine: Chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming. Int. J. Pharm. 2018;535:261–271. doi: 10.1016/j.ijpharm.2017.11.009. PubMed DOI

Wang M., Zhang L., Yang R., Fei C., Wang X., Zhang K., Wang C., Zheng W., Xue F. Improvement of immune responses to influenza vaccine (H5N1) by sulfated yeast beta-glucan. Int. J. Biol. Macromol. 2016;93:203–207. doi: 10.1016/j.ijbiomac.2016.06.057. PubMed DOI

Sima P., Vetvicka V. β-Glucan in Allergies. Am. J. Immunol. 2017;13:73–80.

Kofuji K., Aoki A., Tsubaki K., Konishi M., Isobe T., Murata Y. Antioxidant activity of beta-glucan. ISRN Pharm. 2012;2012:125864. doi: 10.5402/2012/125864. PubMed DOI PMC

Yamada J., Hamuro J., Hatanaka H., Hamabata K., Kinoshita S. Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: A randomized study. J. Allergy Clin. Immunol. 2007;119:1119–1126. doi: 10.1016/j.jaci.2007.02.005. PubMed DOI

Kawashima S., Hirose K., Iwata A., Takahashi K., Ohkubo A., Tamachi T., Ikeda K., Kagami S., Nakajima H. beta-glucan curdlan induces IL-10-producing CD4+ T cells and inhibits allergic airway inflammation. J. Immunol. 2012;189:5713–5721. doi: 10.4049/jimmunol.1201521. PubMed DOI

Jesenak M., Hrubisko M., Majtan J., Rennerova Z., Banovcin P. Anti-allergic effect of Pleuran (beta-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. Phytother. Res. 2014;28:471–474. doi: 10.1002/ptr.5020. PubMed DOI

Miyamoto K., Watanabe Y., Iizuka N., Sakaguchi E., Okita K. Effect of a hot water extract of Agaricus blazei fruiting bodies (CJ-01) on the intracellular cytokines level in a patient with bronchitis. J. Trad Med. 2002;19:142–147.

Talbott S.M., Talbott J.A., Talbott T.L., Dingler E. beta-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers. Food Sci. Nutr. 2013;1:90–101. doi: 10.1002/fsn3.11. PubMed DOI PMC

Yamauchi E., Shoji S., Nishihara M., Shimoda T., Nishima S. Contribution of lung fibroblast migration in the fibrotic process of airway remodeling in asthma. Allergol. Int. 2008;57:73–78. doi: 10.2332/allergolint.O-06-481. PubMed DOI

Fuller R., Butt H., Noakes P.S., Kenyon J., Yam T.S., Calder P.C. Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections. Nutrition. 2012;28:665–669. doi: 10.1016/j.nut.2011.11.012. PubMed DOI

Jesenak M., Banovcin P., Rennerova Z., Majtan J. β-Glucans in the treatment and prevention of allergic diseases. Allergol. Immunopathol. (Madr.) 2014;42:149–156. doi: 10.1016/j.aller.2012.08.008. PubMed DOI

Wichers H. Immunomodulation by food: Promising concept for mitigating allergic disease? Anal. Bioanal. Chem. 2009;395:37–45. doi: 10.1007/s00216-009-2838-1. PubMed DOI PMC

Sarinho E., Medeiros D., Schor D., Rego Silva A., Sales V., Motta M.E., Costa A., Azoubel A., Rizzo J.A. Production of interleukin-10 in asthmatic children after beta-1-3-glucan. Allergol. Immunopathol. (Madr.) 2009;37:188–192. doi: 10.1016/j.aller.2009.02.005. PubMed DOI

Miraglia Del Giudice M., Maiello N., Capristo C., Alterio E., Capasso M., Perrone L., Ciprandi G. Resveratrol plus carboxymethyl-beta-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis. Curr. Med. Res. Opin. 2014;30:1931–1935. doi: 10.1185/03007995.2014.938731. PubMed DOI

Miraglia Del Giudice M., Maiello N., Decimo F., Capasso M., Campana G., Leonardi S., Ciprandi G. Resveratrol plus carboxymethyl-beta-glucan may affect respiratory infections in children with allergic rhinitis. Pediatr. Allergy Immunol. 2014;25:724–728. doi: 10.1111/pai.12279. PubMed DOI

Li F., Jin X., Liu B., Zhuang W., Scalabrin D. Follow-up formula consumption in 3- to 4-year-olds and respiratory infections: An RCT. Pediatrics. 2014;133:e1533–e1540. doi: 10.1542/peds.2013-3598. PubMed DOI

Bobovcak M., Kuniakova R., Gabriz J., Majtan J. Effect of Pleuran (beta-glucan from Pleurotus ostreatus) supplementation on cellular immune response after intensive exercise in elite athletes. Appl. Physiol. Nutr. Metab. 2010;35:755–762. doi: 10.1139/H10-070. PubMed DOI

Majtan J. Pleuran (beta-glucan from Pleurotus ostreatus): An effective nutritional supplement against upper respiratory tract infections? Med. Sport Sci. 2012;59:57–61. doi: 10.1159/000341967. PubMed DOI

Murphy E.A., Davis J.M., Brown A.S., Carmichael M.D., Carson J.A., Van Rooijen N., Ghaffar A., Mayer E.P. Benefits of oat beta-glucan on respiratory infection following exercise stress: Role of lung macrophages. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;294:R1593–R1599. doi: 10.1152/ajpregu.00562.2007. PubMed DOI

Davis J.M., Murphy E.A., Brown A.S., Carmichael M.D., Ghaffar A., Mayer E.P. Effects of oat beta-glucan on innate immunity and infection after exercise stress. Med. Sci. Sports Exerc. 2004;36:1321–1327. doi: 10.1249/01.MSS.0000135790.68893.6D. PubMed DOI

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Hydrocolloids from the Mushroom Auricularia heimuer: Composition and Properties

. 2023 Jun 16 ; 9 (6) : . [epub] 20230616

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...